Literature DB >> 14577598

Phospholamban phosphorylation in ischemia-reperfused heart. Effect of pacing during ischemia and response to a beta-adrenergic challenge.

Cecilia Mundiña-Weilenmann1, Matilde Said, Leticia Vittone, Paola Ferrero, Alicia Mattiazzi.   

Abstract

The status of phospholamban (PLB) phosphorylation in the ischemia-reperfused hearts remains controversial. Although a decrease in the phosphorylation of both PLB residues (Ser16, PKA site, and Thr17, CaMKII site) was previously reported, experiments from our laboratory failed to detect this decrease. In an attempt to elucidate the cause for this discrepancy, experiments were performed in Langendorff-perfused rat hearts with two main goals: (1) To determine whether keeping pacing during ischemia, a protocol followed in other ischemia-reperfusion models, decreases the phosphorylation of PLB residues, below pre-ischemic values; (2) To investigate whether a maximal beta-adrenergic challenge allows to detect a decrease in the ability of PLB to be phosphorylated in ischemia-reperfused hearts. Hearts were submitted to a global ischemia/reperfusion protocol (20/30 min) with (P) or without (NP) pacing during ischemia, and phosphorylation of PLB residues was assessed by immunodetection. The recovery of contractility upon reperfusion was lower in P vs. NP hearts. Ser16 of PLB, was phosphorylated at the end of ischemia in NP hearts. This increase appeared earlier in P hearts and was significantly diminished by catecholamine depletion and beta-blockade. Thr17 site was phosphorylated at the beginning of ischemia and the onset of reperfusion. The ischemia-induced phosphorylation of Thr17 was higher and more sustained in P vs. NP hearts, and inhibited by the calcium channel blocker, nifedipine, whereas the reperfusion-induced increase in Thr17 phosphorylation was similar in P and NP hearts and was significantly diminished by the Na+/Ca2+ exchanger inhibitor KB-R7943. Phosphorylation of PLB residues did not decrease below basal levels at any time during ischemia and reperfusion. However, the phosphorylation, inotropic and lusitropic response to beta-adrenergic stimulation was significantly decreased both in P and NP hearts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14577598     DOI: 10.1023/a:1025504709518

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  24 in total

1.  Biochemical mechanism(s) of stunning in conscious dogs.

Authors:  H Lüss; A Meissner; N Rolf; H Van Aken; P Bokník; U Kirchhefer; J Knapp; S Läer; B Linck; I Lüss; F U Müller; J Neumann; W Schmitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

2.  Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways.

Authors:  Leticia Vittone; Cecilia Mundiña-Weilenmann; Matilde Said; Paola Ferrero; Alicia Mattiazzi
Journal:  J Mol Cell Cardiol       Date:  2002-01       Impact factor: 5.000

3.  Transgenic mouse model of stunned myocardium.

Authors:  A M Murphy; H Kögler; D Georgakopoulos; J L McDonough; D A Kass; J E Van Eyk; E Marbán
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

4.  Sarcoplasmic reticulum calcium uptake in human myocardium subjected to ischemia and reperfusion during cardiac surgery.

Authors:  R Zucchi; S Ronca-Testoni; P Di Napoli; G Yu; S Gallina; G Bosco; G Ronca; A M Calafiore; M Mariani; A Barsotti
Journal:  J Mol Cell Cardiol       Date:  1996-08       Impact factor: 5.000

5.  A model of low-flow ischemia and reperfusion in single, beating adult cardiomyocytes.

Authors:  T G Maddaford; C Hurtado; S Sobrattee; M P Czubryt; G N Pierce
Journal:  Am J Physiol       Date:  1999-08

6.  A novel mechanism for myocardial stunning involving impaired Ca(2+) handling.

Authors:  S J Kim; R K Kudej; A Yatani; Y K Kim; G Takagi; R Honda; D A Colantonio; J E Van Eyk; D E Vatner; R L Rasmusson; S F Vatner
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

7.  Characterization of cardiac sarcoplasmic reticulum dysfunction during short-term, normothermic, global ischemia.

Authors:  S Krause; M L Hess
Journal:  Circ Res       Date:  1984-08       Impact factor: 17.367

8.  The relative relevance of phosphorylation of the Thr(17) residue of phospholamban is different at different levels of beta-adrenergic stimulation.

Authors:  Matilde Said; Cecilia Mundiña-Weilenmann; Leticia Vittone; Alicia Mattiazzi
Journal:  Pflugers Arch       Date:  2002-08-01       Impact factor: 3.657

9.  Phosphorylation of phospholamban in intact myocardium. Role of Ca2+-calmodulin-dependent mechanisms.

Authors:  J P Lindemann; A M Watanabe
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

10.  A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1.

Authors:  T Iwamoto; T Watano; M Shigekawa
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

View more
  4 in total

Review 1.  Chasing cardiac physiology and pathology down the CaMKII cascade.

Authors:  Alicia Mattiazzi; Rosana A Bassani; Ariel L Escobar; Julieta Palomeque; Carlos A Valverde; Martín Vila Petroff; Donald M Bers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

2.  Quantitative cardiac phosphoproteomics profiling during ischemia-reperfusion in an immature swine model.

Authors:  Dolena Ledee; Min A Kang; Masaki Kajimoto; Samuel Purvine; Heather Brewer; Ljiljana Pasa-Tolic; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-04-28       Impact factor: 4.733

3.  Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.

Authors:  Jia Liu; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-15       Impact factor: 4.733

4.  A characterization and targeting of the infarct border zone in a swine model of myocardial infarction.

Authors:  Jason M Duran; Sharven Taghavi; Remus M Berretta; Catherine A Makarewich; Thomas Sharp Iii; Tim Starosta; Foram Udeshi; Jon C George; Hajime Kubo; Steven R Houser
Journal:  Clin Transl Sci       Date:  2012-06-26       Impact factor: 4.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.